kabutan

Ajinomoto Co., Inc.(2802) Summary

2802
TSE Prime
Ajinomoto Co., Inc.
4,405
JPY
+7
(+0.16%)
Mar 13, 3:30 pm JST
27.63
USD
Mar 13, 2:30 am EDT
Result
PTS
outside of trading hours
4,365.3
Mar 13, 10:09 pm JST
Summary Chart Historical News Financial Result
PER
32.5
PBR
5.69
Yield
1.09%
Margin Trading Ratio
0.93
Stock Price
Mar 13, 2026
Opening Mar 13, 9:03 am
4,310 JPY 27.09 USD
Previous Close Mar 12
4,398 JPY 27.66 USD
High Mar 13, 3:21 pm
4,424 JPY 27.76 USD
Low Mar 13, 9:03 am
4,310 JPY 27.09 USD
Volume
3,093,000
Trading Value
0.01T JPY 0.08B USD
VWAP
4369.43 JPY 27.41 USD
Minimum Trading Value
440,500 JPY 2,763 USD
Market Cap
4.31T JPY 0.03T USD
Number of Trades
5,034
Liquidity & Number of Trades
As of Mar 13, 2026
Liquidity
High
1-Year Average
5,572
1-Year High Feb 6, 2026
27,071
Margin Trading
Date Short Interest Long Margin Positions Ratio
Mar 6, 2026 182,600 974,400 5.34
Feb 27, 2026 275,500 1,174,800 4.26
Feb 20, 2026 276,600 1,293,900 4.68
Feb 13, 2026 264,700 1,255,100 4.74
Feb 6, 2026 412,900 1,807,500 4.38
Company Profile
Ajinomoto Co., Inc. is a leading comprehensive food company, ranking first in seasonings. The company has diversified into pharmaceuticals, animal feed, and other sectors, and is actively pursuing M&A opportunities.
Sector
Foods
Ajinomoto Co., Inc. is a comprehensive food manufacturer with a primary focus on seasonings, nutritional and processed foods, solution and ingredients, and frozen foods. The company also operates in non-food sectors, including pharmaceutical and food-grade amino acids, biopharmaceutical services (CDMO), and functional materials (such as electronic materials). With numerous subsidiaries both domestically and internationally, Ajinomoto conducts business on a global scale. The company has particularly strong business foundations in Southeast Asia and South America. In the seasoning business, Ajinomoto has local subsidiaries in Thailand, Indonesia, Vietnam, the Philippines, and Malaysia, among others. The frozen food business has also expanded into North America. Additionally, the company is focusing on strengthening its biopharmaceutical services business.